Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment [Phase 3]
A Phase 3 trial evaluating empagliflozin in adults with type 2 diabetes and renal impairment has completed. The results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: ONSET and OFFSET of Ticagrelor in ESRD [Phase 3]
A Phase 3 clinical trial evaluating the onset and offset of ticagrelor in patients with chronic kidney disease and end-stage renal disease h…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Comparative Investigation of Intravenously Administered Omnipaque and Isovue: Effects on Serum Creatinine Concentration in Outpatients [NA]
A completed clinical trial comparing intravenous iohexol (Omnipaque) versus iopamidol (Isovue) on serum creatinine in outpatients with kidne…
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Application of Citrate Dialysate in Chronic Haemodialysis [NA]
A completed clinical trial evaluating citrate dialysate in patients undergoing chronic haemodialysis.
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease [Phase 3]
A Phase 3 trial evaluating monthly dosing of darbepoetin alfa for correcting anemia in non-dialysis chronic kidney disease has completed and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Effect of Exercise on Renal Function in Predialysis [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating whether exercise improves renal function in predialysis patients with chronic kidney d…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis [Phase 3]
A Phase 3 study evaluating conversion from epoetin alfa to monthly peginesatide injections in chronic kidney disease patients on dialysis; r…
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients [Phase 3]
Phase 3 STIMULATE trial evaluating anemia correction and health-related quality of life in elderly patients with chronic kidney disease. The…
-
CLINICAL_TRIALS withdrawal · 2014-05-21Clinical Trial Update: Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease [NA]
A clinical trial evaluating the effects of Vitamin D on renal blood flow, proteinuria, and inflammation in chronic kidney disease was withdr…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Neck-Worn Monitoring Sensor for - A Study for Monitoring Subjects With Fluid-Management Issues During Dialysis
Completed clinical trial evaluating a neck-worn sensor for monitoring fluid management in dialysis patients, sponsored by Baxter Healthcare …
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Study of Erythropoietin (EPO) Administration Schedule [Phase 4]
Phase 4 clinical trial evaluating the schedule of erythropoietin administration in patients with chronic kidney disease and anemia has been …
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia [Phase 3]
Phase 3 study of MCI-196 in patients with chronic kidney disease on dialysis and hyperphosphatemia has completed; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Effect of Replacement Volume of Haemodiafiltration and AST-120 on Toxins, Oxidative Stress and MicroInflammation [Phase 4]
Phase 4 clinical trial update evaluating how replacement volume in haemodiafiltration and the oral carbon adsorbent AST-120 affect toxin lev…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) [Phase 3]
Phase 3 trial update on ferric carboxymaltose for iron deficiency anemia in non-dialysis-dependent chronic kidney disease. Results were post…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Niacin and Endothelial Function in Early CKD [Phase 4]
Phase 4 trial evaluating the effect of niacin on endothelial function in adults with early chronic kidney disease has completed and posted r…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluated heme iron polypeptide for iron-deficiency anemia in chronic kidney disease; the study is completed and res…
-
CLINICAL_TRIALS research · 2014-05-01Clinical Trial Update: Developing and Evaluating the Yorkshire Dialysis Decision Aid [Phase 1]
This document provides an update on a Phase 1 study evaluating a dialysis decision aid for patients with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Effect of Intradialytic Physical ACTIvity in Addition to a NUTritional Support on Protein Energy Wasting and Physical Functioning in Chronic Hemodialysis Patients ("ACTINUT" Study) [NA]
The ACTINUT trial evaluating intradialytic physical activity plus nutritional support in chronic hemodialysis patients has been terminated.
-
FDA approval · 2014-04-24FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX, a dialysis solution consisting of dextrose and electrolytes, produced by Fresenius Medi…
-
FDA approval · 2014-04-23FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approved a supplemental application for DELFLEX, a dialysate solution from Fresenius Medical Care de Mexico, S.A. de C.V., updating the …
-
FDA approval · 2014-04-23FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX dialysis solution from Fresenius Medical Care North America.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Prevalence of Fatigue in Hemodialysis Patients
A completed clinical trial update from National Taiwan University Hospital reports the prevalence of fatigue among patients undergoing hemod…
-
FDA approval · 2014-04-17FDA Approved: ARANESP — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for ARANESP (darbepoetin alfa) from Amgen.
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Reducing Hemodialysis Catheter Use in Prevalent Hemodialysis Patients [Phase 2]
Phase 2 clinical trial investigating reduction of hemodialysis catheter use in prevalent hemodialysis patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients [NA]
The trial investigating the effect of epinephrine on systemic absorption of mepivacaine in uremic patients has been terminated.